News
Good News | Wanbangde Pharmaceutical Group has once again earned two prestigious awards: "Outstanding Chinese Ethnic Medicine Brand Enterprise" and "Top 50 Growing Companies in China's Pharmaceutical Industry"!
Date:
11 May,2023
From March 25 to 27, the annual summit of the All-China Federation of Industry and Commerce Pharmaceutical Industry Chamber was grandly held in Qingdao. The conference aimed to deeply study and implement the spirit of the 20th National Congress of the Communist Party of China and the Central Economic Work Conference, while also providing insights into the current state of China's pharmaceutical industry. Renowned experts and industry leaders gathered together to focus on key areas driving the pharmaceutical sector, collaboratively discussing strategies for the industry's growth and working together to build a brighter future for all.
On the evening of March 26, a series of prestigious lists—including the Most Influential Brands in China's Pharmaceutical Industry for 2021-2022 and Outstanding Chinese National Medicine Brand Enterprises—were officially unveiled at the summit. Wanbangde Pharmaceutical Group Co., Ltd. emerged as a winner. "2021 Outstanding Chinese National Medicine Brand Enterprise" (Representative Product: Ginkgo Leaf Droplets) And "Top 50 Fast-Growing Chinese Pharmaceutical Companies of 2021" Two major awards!
Honors (I)
2021 Annual Outstanding Brand Enterprise of Chinese National Medicine
(Featured Product: Ginkgo Leaf Droplets)
Honors (Part 2)
China's Top 50 Fastest-Growing Companies in the Pharmaceutical Industry for 2021
Notably, this marks another milestone for Wanbande, following its previous accolades as the "2020 Outstanding Chinese Ethnic Medicine Brand Enterprise" (with its flagship product, Ginkgo Leaf Droplets) and recognition as one of the "Top 50 Fast-Growing Companies in China's Pharmaceutical Industry in 2019." Most recently, Wanbande has once again been honored as the "2021 Outstanding Chinese Ethnic Medicine Brand Enterprise" (again featuring its star product, Ginkgo Leaf Droplets), as well as being named to the "2021 China Pharmaceutical Industry's Most Influential List—Top 50 Fast-Growing Companies in China's Pharmaceutical Sector."
Winning these two major awards is not only a testament to our honor but also reflects the industry's high recognition of the Group's growing reputation and influence. By shaping brand value and setting an inspiring example, Wanbangde Pharmaceutical Group will continue to champion national medicine culture, stay true to our core mission as healthcare professionals, and actively contribute to the vibrant and sustainable development of the pharmaceutical industry!
Related Recommendations